This is a cross-over intervention study designed to evaluate how four weeks of time restricted feeding (16 hours fasting and 8 hours feeding), compared to four weeks of a more traditional eating pattern (12 hours fasting and 12 hours feeding), affects resting energy expenditure, subjective and biochemical markers of satiety and hunger, body composition, cardiovascular health, substrate utilization and fitness in male competitive runners.
Weight loss and improvements in body composition (increasing muscle mass and decreasing fat mass) are common goals for both dieters and athletes. Although a traditional method of achieving this has been accomplished through caloric restriction, an alternate method that is becoming increasingly popular is fasting. Fasting is described as the absence of food and/or calorie-containing beverage consumption for a period of time. The majority of people fast for 8-10 hours daily, which occurs during the overnight period when people are asleep Intermittent fasting, specifically time-restricted feeding (TRF), has recently gained popularity because it is a more sustainable means of practicing fasting and it has been shown to enhance the loss of fat mass with or without caloric restriction. It has also been shown to enhance overall health due to reports of reduced fasting glucose, insulin resistance, triglycerides, and reduced total and low-density lipoprotein (LDL) cholesterol levels in obese women. Despite its growing popularity among athletes, there is scarce research on how adhering to this type of diet pattern affects athletic performance and other biochemical markers related to health. The participants in this study will be randomly assigned to either a traditional (12/12) or a time restrictive (16/8) eating pattern in a crossover design. Each pattern will last for four weeks with a minimum two week washout in between, and the participants will consume the same calorie and macronutrient amounts based on recommendations made by the American College of Sports Medicine (ACSM) for both eating patterns. The 12/12 pattern will require subjects to consume 5 meals (breakfast, lunch, dinner, and two snacks) per day within a 12 hour period suggested to be around 8am, 10am, 12pm, 3pm, and 7pm. The 16/8 pattern will require subjects to consume 3 meals in an 8-hour period suggested to be around 12pm, 3pm, and 7pm. Subjects may only consume water, unsweetened coffee, or unsweetened tea (no artificial sweeteners) during their periods of fasting. Subjects will perform all exercise in the morning before 8 am in the fasted state. Subjects will visit the Western Human Nutrition Research Center (WHNRC) for test days at baseline (study day 1), after four weeks of the first dietary intervention (study day 28), and at the start (study day 43) and end of the second dietary intervention (study day 70), for a total of 4 test days over the duration of 10 weeks.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Enrollment
21
Volunteers will adhere to a form of time restrictive feeding, 16 hours fasting and 8 hours eating per day.
Volunteers will adhere to a more traditional eating pattern, 12 hours fasted and 12 hours eating per day.
UC Davis, Western Human Nutrition Research Center
Davis, California, United States
Change in resting energy expenditure
Resting energy expenditure will be measured using a metabolic cart
Time frame: Study day 1, 28, 43 and 70
Change in body composition
Body composition, including fat mass and lean body mass, will be measured by dual-energy x-ray absorptiometry (DEXA) and expressed in kilograms (kg).
Time frame: Study day 1, 28, 43 and 70
Change in substrate utilization during exercise
Carbohydrate and fat utilized for energy will be measured using a metabolic cart
Time frame: Study day 1, 28, 43 and 70
Change in cardiovascular fitness
Time to run a 10 kilometer time trial on a treadmill expressed in minutes
Time frame: Study day 1, 28, 43 and 70
Change in perceived feelings of hunger and fullness
Perceived hunger and fullness will be measured using a visual analog scale. Responses will be a mark on an unsegmented line from 0 or "not at all" to 5 or "extremely."
Time frame: Study day 1, 28, 43 and 70
Change in glucagon, a biomarker of hunger and satiety
Fasting plasma will be analyzed for glucagon (pmol/L) as measured by enzyme-linked immunoabsorbant assay
Time frame: Study day 1, 28, 43 and 70
Change in leptin, a biomarker of hunger and satiety
Fasting plasma will be analyzed for leptin (pmol/L) as measured by enzyme-linked immunoabsorbant assay
Time frame: Study day 1, 28, 43 and 70
Change in ghrelin, a biomarker of hunger and satiety
Fasting plasma will be analyzed for ghrelin (pmol/L) as measured by enzyme-linked immunoabsorbant assay
Time frame: Study day 1, 28, 43 and 70
Change in insulin
Fasting plasma will be analyzed for insulin (pmol/L) as measured by enzyme-linked immunoabsorbant assay
Time frame: Study day 1, 28, 43 and 70
Change in total cholesterol, a biomarker of cardiovascular health
Fasting serum will be analyzed for total cholesterol (mmol/L) by Piccolo analyzer
Time frame: Study day 1, 28, 43 and 70
Change in HDL cholesterol, a biomarker of cardiovascular health
Fasting serum will be analyzed for HDL cholesterol (mmol/L) by Piccolo analyzer
Time frame: Study day 1, 28, 43 and 70
Change in LDL cholesterol, a biomarker of cardiovascular health
Fasting serum will be analyzed for LDL cholesterol (mmol/L) by Piccolo analyzer
Time frame: Study day 1, 28, 43 and 70
Change in very low-density lipoprotein (VLDL), a biomarker of cardiovascular health
Fasting serum will be analyzed for very low-density lipoprotein (VLDL) cholesterol (mmol/L) by Piccolo analyzer
Time frame: Study day 1, 28, 43 and 70
Change in triglycerides, a biomarker of cardiovascular health
Fasting serum will be analyzed for triglycerides (mmol/L) by Piccolo analyzer
Time frame: Study day 1, 28, 43 and 70
Change in alanine aminotransferase, a biomarker of cardiovascular health
Fasting serum will be analyzed for alanine aminotransferase (IU/L) by Piccolo analyzer
Time frame: Study day 1, 28, 43 and 70
Change in aspartate aminotransferase, a biomarker of cardiovascular health
Fasting serum will be analyzed for aspartate aminotransferase (IU/L) by Piccolo analyzer
Time frame: Study day 1, 28, 43 and 70
Change in glucose
Fasting serum will be analyzed for glucose (mmol/L) by Piccolo analyzer
Time frame: Study day 1, 28, 43 and 70
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.